290 related articles for article (PubMed ID: 12895416)
21. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
Ji G; Neugebauer V
J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice.
Albrechet-Souza L; Hwa LS; Han X; Zhang EY; DeBold JF; Miczek KA
Alcohol Clin Exp Res; 2015 Sep; 39(9):1609-18. PubMed ID: 26247973
[TBL] [Abstract][Full Text] [Related]
23. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
Lu L; Liu Z; Huang M; Zhang Z
J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
[TBL] [Abstract][Full Text] [Related]
24. Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists.
Heikkinen AE; Möykkynen TP; Korpi ER
Neuropsychopharmacology; 2009 Jan; 34(2):290-8. PubMed ID: 18563060
[TBL] [Abstract][Full Text] [Related]
25. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning.
Blank T; Nijholt I; Grammatopoulos DK; Randeva HS; Hillhouse EW; Spiess J
J Neurosci; 2003 Jan; 23(2):700-7. PubMed ID: 12533630
[TBL] [Abstract][Full Text] [Related]
26. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance.
Richard D; Lin Q; Timofeeva E
Eur J Pharmacol; 2002 Apr; 440(2-3):189-97. PubMed ID: 12007535
[TBL] [Abstract][Full Text] [Related]
27. Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration.
Orozco-Cabal L; Liu J; Pollandt S; Schmidt K; Shinnick-Gallagher P; Gallagher JP
J Neurosci; 2008 Jan; 28(2):529-42. PubMed ID: 18184795
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor depolarizes rat lateral vestibular nuclear neurons through activation of CRF receptors 1 and 2.
Wang Y; Chen ZP; Yang ZQ; Zhang XY; Li JM; Wang JJ; Zhu JN
Neuropeptides; 2019 Aug; 76():101934. PubMed ID: 31130301
[TBL] [Abstract][Full Text] [Related]
29. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells.
Kim Y; Park MK; Uhm DY; Chung S
Biochem Biophys Res Commun; 2007 Jul; 358(3):796-801. PubMed ID: 17506983
[TBL] [Abstract][Full Text] [Related]
30. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
31. Corticotropin-releasing factor (CRF) and urocortin promote the survival of cultured cerebellar GABAergic neurons through the type 1 CRF receptor.
Choi JS; Pham TT; Jang YJ; Bui BC; Lee BH; Joo KM; Cha CI; Lee KH
J Korean Med Sci; 2006 Jun; 21(3):518-26. PubMed ID: 16778399
[TBL] [Abstract][Full Text] [Related]
32. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus.
Chen Y; Bender RA; Brunson KL; Pomper JK; Grigoriadis DE; Wurst W; Baram TZ
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15782-7. PubMed ID: 15496472
[TBL] [Abstract][Full Text] [Related]
33. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
34. Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.
Schreiber AL; Gilpin NW
Handb Exp Pharmacol; 2018; 248():435-471. PubMed ID: 29374836
[TBL] [Abstract][Full Text] [Related]
35. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.
Borgland SL; Taha SA; Sarti F; Fields HL; Bonci A
Neuron; 2006 Feb; 49(4):589-601. PubMed ID: 16476667
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
[TBL] [Abstract][Full Text] [Related]
37. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing factor binding protein enters the regulated secretory pathway in neuroendocrine cells and cortical neurons.
Blanco EH; Zúñiga JP; Andrés ME; Alvarez AR; Gysling K
Neuropeptides; 2011 Aug; 45(4):273-9. PubMed ID: 21624661
[TBL] [Abstract][Full Text] [Related]
39. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.
Behan DP; Grigoriadis DE; Lovenberg T; Chalmers D; Heinrichs S; Liaw C; De Souza EB
Mol Psychiatry; 1996 Sep; 1(4):265-77. PubMed ID: 9118350
[TBL] [Abstract][Full Text] [Related]
40. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
Miguel TT; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
